Tandem CAG Repeats of the Androgen Receptor Gene and Prostate Cancer Risk in Black and White Men
- 1 January 2001
- journal article
- Published by Springer Nature in Endocrine
- Vol. 15 (2) , 213-216
- https://doi.org/10.1385/endo:15:2:213
Abstract
The most common malignancy in men worldwide is cancer of the prostate. Androgens play a direct role in normal and malignant growth of prostate cells via the androgen receptor (AR). This study analyzed the polymorphic CAG repeat sequence in exon 1 of the AR gene to determine if the number of repeats might be an indicator of prostate cancer risk or aggressive disease. DNA was extracted from blood samples of 20 black and 20 white men with well-documented prostate cancer and 40 healthy, controls (20 blacks and 20 whites). PCR amplifications was followed by gel electrophoresis and DNA sequencing. This region normally contains between 9 and 29 repeats. Patients and controls both had minor variations in the number of repeats, which ranged from 13 to 27 with 21 being the most frequent allele. Black controls and patients both had a mean of 20±3, repeats; in whites the mean was significantly lower in patients than controls (21±2 versus 23±2; p=0.004). Combined black and white patients also had a lower number than the combined group of controls (20±3 versus 22±3; p=0.02). Similarly, black and white patients with aggressive disease has a lower number than patients whose disease was more slowly progressive (19±2 versus 22±3; p=0.02). We conclude that the small differences in the number of CAG repeats in both black and white patients do not appear to be a strong indicator of risk or aggressive disease but that this size polymorphism may be one of many genetic and environmental risk factors involved in prostate cancer.Keywords
This publication has 21 references indexed in Scilit:
- Hormonal Signaling in Prostatic Hyperplasia and Neoplasia*Journal of Clinical Endocrinology & Metabolism, 1999
- CAG repeat length in the androgen receptor gene is related to age at diagnosis of prostate cancer and response to endocrine therapy, but not to prostate cancer riskBritish Journal of Cancer, 1999
- Cancer statistics, 1999CA: A Cancer Journal for Clinicians, 1999
- Low Serum Testosterone and a Younger Age Predict for a Poor Outcome in Metastatic Prostate CancerAmerican Journal of Clinical Oncology, 1997
- Polymorphic repeats in the androgen receptor gene: molecular markers of prostate cancer risk.1997
- The CAG and GGC microsatellites of the androgen receptor gene are in linkage disequilibrium in men with prostate cancer.1995
- The length and location of CAG trinucleotide repeats in the androgen receptor N-terminal domain affect transactivation functionNucleic Acids Research, 1994
- Genetic variation at five trimeric and tetrameric tandem repeat loci in four human population groupsGenomics, 1992
- Domains of the Human Androgen Receptor Involved in Steroid Binding, Transcriptional Activation, and Subcellular LocalizationMolecular Endocrinology, 1991
- Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophyNature, 1991